Cargando…
The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study
Background: Past studies suggest mixed associations between selective serotonin reuptake inhibitor (SSRI) prescription and carcinogenic risk. There is no epidemiological study reporting on the association between SSRI use and the incidence of bladder cancer. The aim of this study is to determine whe...
Autores principales: | Liu, Yi-Chun, Chen, Vincent Chin-Hung, Lu, Mong-Liang, Lee, Min-Jing, McIntyre, Roger S., Majeed, Amna, Lee, Yena, Chen, Yi-Lung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281365/ https://www.ncbi.nlm.nih.gov/pubmed/32392848 http://dx.doi.org/10.3390/cancers12051184 |
Ejemplares similares
-
Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study
por: Chen, Vincent Chin-Hung, et al.
Publicado: (2017) -
Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011) -
Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs)
por: Jannini, Tommaso B., et al.
Publicado: (2022) -
Association between selective serotonin reuptake inhibitor and risk of peripheral artery disease in diabetes mellitus: Propensity score matching and landmark analysis
por: Chen, Kai-Hua, et al.
Publicado: (2022) -
Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?
por: Sneep, S., et al.
Publicado: (2022)